Clinical Trial Update: Intra-coronary Infusion of Bone Marrow Derived Autologous CD34+ Selected Cells in Patients With Acute Myocardial Infarction [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating intra-coronary infusion of autologous CD34+ selected bone marrow cells in patients with acute myocardial infarction; the study has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Myocardial Infarction

Drugs mentioned

• Autologous CD34+ selected bone marrow cells

Snippet

Sponsor: Emory University | Conditions: Myocardial Infarction, Coronary Artery Disease | Phase 1 | Status: COMPLETED